Literature DB >> 17331290

Persistent sexual arousal in a woman with associated cardiac defects and raised atrial natriuretic peptide.

C Bell1, D Richardson, D Goldmeier, T Crowley, A Kocsis, S Hill.   

Abstract

The persistent sexual arousal syndrome (PSAS) is a newly described entity where the woman becomes involuntarily genitally aroused for extended periods of time in the absence of sexual desire and is distressed by this situation. The cause of this sexual problem is not well understood. We describe such a case where the subjective feelings were confirmed by observing genital engorgement. In her case, PSAS came on after initiation of fludrocortisone given for hypotension and bradycardia that was associated with an atrial septal defect (ASD). We argue that the combined effect of the ASD and fludrocortisone may be associated with an increase in her levels of atrial natriuretic peptide (ANP). ANP causes profound vasodilation and vascular leakage. We postulate that the high serum levels of ANP in her case may be contributory to her PSAS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331290     DOI: 10.1258/095646207779949592

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  3 in total

1.  Neutral endopeptidase inhibition: could it have a role in the treatment of female sexual arousal disorder?

Authors:  Javier Angulo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  UK-414,495, a selective inhibitor of neutral endopeptidase, potentiates pelvic nerve-stimulated increases in female genital blood flow in the anaesthetized rabbit.

Authors:  C P Wayman; D Baxter; L Turner; P H Van Der Graaf; A M Naylor
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Persistent genital arousal disorder: a clinical challenge.

Authors:  Amin Gadit
Journal:  BMJ Case Rep       Date:  2013-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.